1. Kaiser M, Schiller J, Schreckenberger C. The effectiveness of a population-based skin cancer screening program: evidence from Germany. Eur J Health Econ . 2018:19:355-367.
2. Waldmann A, Nolte S, Weinstock MA, et al. Skin cancer screening participation and impact on melanoma incidence in Germany—an observational study on incidence trends in regions with and without population-based screening. Br J Cancer . 2012;106:970-974.
3. Aitken JF, Janda M, Elwood M, et al. Clinical outcomes from skin screening clinics within a community-based melanoma screening program. J Am Acad Dermatol . 2006:54:105-114.
4. Fritschi L, Dye SA, Katris P. Validity of melanoma diagnosis in a community-based screening program. Am J Epidemiol . 2006:164:385-390.
5. Aitken JF, Elwood M, Baade PD, et al. Clinical whole-body skin examination reduces the incidence of thick melanomas. Int J Cancer . 2010:126:450-458.
6. Wernli KJ, Henrikson NB, Morrison CC, et al. Screening for Skin Cancer in Adults: An Updated Systematic Evidence Review for the US Preventive Services Task Force . Rockville, MD: Agency for Healthcare Research and Quality; 2016. Evidence Synthesis 137.
7. Waldmann A, Nolte S, Geller AC, et al. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations. Arch Dermatol . 2012:148:903-910.
8. US Preventive Services Task Force. Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement. JAMA . 2016;316:429-435.
9. Torres A. AAD statement on USPSTF recommendation on skin cancer screening. July 2016. https://www.aad.org/media/news-releases/aad-statement-on-uspstf 26 . Accessed May 2018.